New research:
Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus iv therapy with ceftriaxone followed by oral trimethoprim–sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00797-7/fulltext
Oral treatment of Whipple's disease with doxycycline and hydroxychloroquine versus iv therapy with ceftriaxone followed by oral trimethoprim–sulfamethoxazole in Germany: a phase 2/3, prospective, open-label, randomised, controlled trial
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00797-7/fulltext
Comments
Whipple's disease: from in-vitro data to bedside practice via trial results
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00016-7/fulltext